Ascendis Pharma A/S (ASND) Financials

ASND Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 912.7 million 1.1 billion
2023-09-30 924.4 million 1.0 billion
2023-06-30 895.8 million 825.3 million
2023-03-31 1.1 billion 871.0 million

ASND Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -46.9 million 17.6 million
2023-09-30 -133.1 million 18.2 million
2023-06-30 -167.0 million 21.6 million
2023-03-31 -161.5 million 14.9 million

ASND Net Income

No data available :(

ASND Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 441.6 million - 109.2 million
2023-09-30 482.1 million - 110.7 million
2023-06-30 468.8 million - -
2023-03-31 638.5 million - -

ASND Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 62.6 million
2023-09-30 59.6 million
2023-06-30 61.1 million
2023-03-31 61.1 million

ASND Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 69643 100.5 million 70.7 million -
2023-09-30 1.0 million 118.0 million 67.3 million -
2023-06-30 482776 114.2 million 76.4 million -
2023-03-31 1.2 million 115.7 million 72.5 million -

ASND Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 152.2 million 21.5 million
2023-09-30 50.9 million 7.8 million
2023-06-30 51.5 million 14.1 million
2023-03-31 36.6 million 5.0 million

ASND

Price: $141.01

52 week price:
66.03
161.00

Earnings Per Share: -9.19 USD

P/E Ratio: -12.10

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 126716

Ebitda: -36.5 million

Market Capitalization: 7.7 billion

Links: